| Open Document File Size: 64,64 KBShare Result on Facebook
City Atlanta / Rockville / / Company BioCryst Pharmaceuticals Inc. / M.D. Principal Deputy / / Country United States / / Event FDA Phase / Person Communication and Meetings / / IndustryTerm peramivir product / above peramivir product / manufacturing / online internet access such reports / manufacturing practice / / MedicalCondition severe allergic reaction / H1N1 infection / disease / Swine Influenza A / systemic illness / renal insufficiency / H1N1 influenza virus / infection / illness / MS / influenza / nonsubtypable influenza A / involving Swine Influenza A / / MedicalTreatment medication errors / hemodialysis / renal replacement therapy / antiviral therapy / / Movie D.5 / D.4 / / Organization National Institute of Health / Food and Drug Administration / Department of Health and Human Services / Centers for Disease Control and Prevention / / Person Silver Spring / Joshua M. Sharfstein / Fact Sheet / Thomas R. Frieden / / / Position Acting Secretary / Commissioner / MPH Director / Secretary / / Product Peramivir injection / peramivir / / ProvinceOrState Maryland / Georgia / / Technology drug delivery / pdf / / URL www.fda.gov/medwatch/report.htm / http /
SocialTag |
Letter of Authorization amendment